Daly A K, Fairbrother K S, Smart J
Department of Pharmacological Sciences, Medical School, University of Newcastle upon Tyne, UK.
Toxicol Lett. 1998 Dec 28;102-103:143-7. doi: 10.1016/s0378-4274(98)00299-9.
The cytochrome P450 superfamily is known to exhibit a high degree of genetic polymorphism and polymorphisms associated with absent or low enzyme activity in CYP2D6, CYP2C19 and CYP2C9 are particularly well studied. However, despite early reports of strong disease associations for particular CYP2D6 phenotypes, these have not been confirmed in recent, more detailed studies and it now appears that analysis of CYP2D6, CYP2C19 and CYP2C9 genotype is of most value in predicting metabolism of specific drugs. Polymorphisms in other cytochrome P450 genes are less well studied and appear not to be associated with complete absence of enzyme activity. We have recently carried out studies of polymorphism in both CYP1A1 and CYP2E1. The molecular basis of the apparent CYP1A1 'high inducibility' polymorphism was investigated by studying CYP1A1 and Ah receptor polymorphisms in a group of phenotyped individuals who were genotyped both for known and novel CYP1A1 and Ah receptor polymorphisms. Three novel polymorphisms in CYP1A1 (C(-459)T, G(-469)A and C(4151)T) and one in the Ah receptor (G(1768)A; V(570)I) were detected by single strand conformational polymorphism analysis and DNA sequencing. Among both novel and previously known polymorphisms, only the Ah receptor G(1721)A polymorphism, which has an allele frequency of 0.12 in Caucasians and was detected previously in a Japanese population, was significantly associated with high induced CYP1A1 activity. In the case of CYP2E1, we have detected three polymorphisms in the promoter region (A(-316)G, T(-297)A and G(-35)T) and one in the coding sequence (G(4804)A; V(179)I) by screening Caucasian DNA samples. The significance of these alleles has been investigated but only G(-35)T combined with T(-297)A, which has an allele frequency of 0.05, appears to be of functional significance, with an apparent 1.8-fold increase in levels of transcriptional activity compared with the wild-type.
细胞色素P450超家族具有高度的遗传多态性,其中与CYP2D6、CYP2C19和CYP2C9酶活性缺失或降低相关的多态性得到了特别深入的研究。然而,尽管早期有报道称特定的CYP2D6表型与疾病有很强的关联,但在近期更详细的研究中并未得到证实,现在看来,分析CYP2D6、CYP2C19和CYP2C9基因型对于预测特定药物的代谢最有价值。其他细胞色素P450基因的多态性研究较少,似乎与酶活性完全缺失无关。我们最近对CYP1A1和CYP2E1的多态性进行了研究。通过对一组已进行表型分析的个体进行CYP1A1和芳烃受体多态性的基因分型,研究了明显的CYP1A1“高诱导性”多态性的分子基础,这些个体针对已知和新的CYP1A1及芳烃受体多态性进行了基因分型。通过单链构象多态性分析和DNA测序,在CYP1A1中检测到三个新的多态性(C(-459)T、G(-469)A和C(4151)T),在芳烃受体中检测到一个新的多态性(G(1768)A;V(570)I)。在新的和先前已知的多态性中,只有芳烃受体G(1721)A多态性与高诱导的CYP1A1活性显著相关,该多态性在白种人中的等位基因频率为0.12,先前在日本人群中也有检测到。就CYP2E1而言,我们通过筛选白种人的DNA样本,在启动子区域检测到三个多态性(A(-316)G、T(-297)A和G(-35)T),在编码序列中检测到一个多态性(G(4804)A;V(179)I)。已经对这些等位基因的意义进行了研究,但只有G(-35)T与T(-297)A组合(等位基因频率为0.05)似乎具有功能意义,与野生型相比,转录活性水平明显增加了1.8倍。